Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$7.78 - $15.31 $238,200 - $468,746
-30,617 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$14.25 - $23.53 $436,292 - $720,418
30,617 New
30,617 $455,000
Q4 2020

Feb 10, 2021

SELL
$10.16 - $23.98 $524,357 - $1.24 Million
-51,610 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$7.44 - $13.15 $245,505 - $433,923
-32,998 Reduced 39.0%
51,610 $518,000
Q2 2020

Aug 10, 2020

BUY
$7.24 - $11.05 $612,561 - $934,918
84,608 New
84,608 $656,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $140M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Martingale Asset Management L P Portfolio

Follow Martingale Asset Management L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

News

Stay updated on Martingale Asset Management L P with notifications on news.